- 1.
- 2.Quarterly Psychedelics Briefing: Q3 2026 (psychedelicalpha.com)
- 3.
- 4.10th Anniversary of the Chacruna Institute (chacruna.net)
- 5.
- 7.
- 8.
- 9.Podcast: Psychedelics in D.C., FDA’s Framework, and New Zealand’s MDMA Prescribers (psychedelicalpha.com)
- 10.Introducing The Psychedelic News Feed Podcast (psychedelicalpha.com)
- 11.Entropy secures South African patent - The Australian (news.google.com)
- 12.Field Notes #5: ‘Psychedelics Week’ in Washington D.C. (psychedelicalpha.com)
- 13.‘Move Fast, with Precision’: Notes from ARPA-H’s Ibogaine Workshop (psychedelicalpha.com)
- 15.No Questions Asked: FDA’s Psychedelics Public Hearing (psychedelicalpha.com)
- 16.Definium Notches Second Positive Phase 3 in Generalised Anxiety Disorder (psychedelicalpha.com)
- 18.Approvals to Access: A Crude Schematic (psychedelicalpha.com)
- 19.The Case That Shook Céu do Mar (chacruna.net)
- 20.Davis, Farchione and Colleagues Present FDA’s Psychedelic Drug Framework in NEJM (psychedelicalpha.com)
- 21.Two New Zealand Psychiatrists Approved to Prescribe MDMA for PTSD (psychedelicalpha.com)
- 22.Pα+ Library: Psychedelic REMS (psychedelicalpha.com)
- 25.MAPS Announces Agreement with UAB (maps.org)
- 26.
- 27.A Closer Look at Definium’s Phase 3 LSD for GAD Readout (psychedelicalpha.com)
- 29.Queering Psychedelics (chacruna.net)
- 30.Psychedelic Policy Briefing 8.21.26 (lucid.news)